Successful treatment of T-cell prolymphocytic leukemia with full-intensity conditioning followed by matched unrelated donor allogeneic stem cell transplantation

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 11, 2007, Pages 882-884

  Kruspe, Rachel C ^a   Ashraf, Khaleel K ^a   Foran, James M ^a   Salzman, Donna E ^a   Reddy, Vishnu V B ^a   Vaughan, William P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HEMOGLOBIN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD ANALYSIS; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MUCOSA INFLAMMATION; MYELOABLATIVE CONDITIONING; PATIENT REFERRAL; PROLYMPHOCYTIC LEUKEMIA; SEIZURE; T CELL LEUKEMIA; THROMBOCYTE COUNT; TREATMENT OUTCOME; ALLOTRANSPLANTATION; EPILEPSY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; REVIEW;

ADULT; EPILEPSY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, PROLYMPHOCYTIC, T-CELL; MALE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 38849155982     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Pawson R, Dyer MJS, Barge R, et al. Treatment of T-cell prolymphocytic leukemia with human CD52 antibody. J Clin Oncol. 1997; 15:2667-2672.
2. Dearden C, Matures E, Cazin B, et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood. 2001;98:1721-1726.
3. Curtin NJ, Schwarer AP. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility. Clin Lab Haematol. 2005;27:206-208.
4. Globrial I, Bunch T, Caplice N, et al. Fatal coronary artery disease after unrelated donor bone marrow transplantation. Mayo Clin Proc. 2004;79:403-406.
5. Collins RH, Piñeiro LA, Agora ED, Fay JW. Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation. Bone Marrow Transplant. 1998;21:627-628.
6. Murase K, Matsunaga T, Sato T, et al. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement. Int J Clin Oncol. 2003;8:391-394.
7. Tanimoto TE, Hirano A, Nagafuji K, et al. Mismatched unrelated cord blood transplantation in a patient with T-cell prolymphocytic leukemia. Leukemia. 2005;19:679-681.
8. Garderet L, Bittencourt H, Kaliski A, et al. Treatment of T-prolymphocytic leukemia with non-myeloablative allogeneic stem cell transplantation. Eur J Haematol. 2001;66:137-139.
9. de Lavallade H, Faucher C, Fürst S, et al. Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission. Bone Marrrow Transplant. 2006;37:709-710.
10. Okamura K, Ikeda T, Shimakura Y, et al. Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia. Rinsho Ketsueki. 2005;46:527-531.